Early bird registration and abstract submission is OPEN

〰️

Early bird registration and abstract submission is OPEN 〰️

The annual International Symposium on Hepatitis C Virus, Flaviviruses and Related Viruses is recognised internationally as the premier meeting for researchers working in the HCV and related flavivirus fields. Rotating through meeting venues in Europe, North America and Asia/Australia since 1994, the meeting has played a key role in both promoting excellence in research, driving discoveries in virus replication, pathogenesis and genetics, and providing the knowledge base for the spectacular advances in antiviral and vaccine development.

While HCV was originally the main focus of the symposium, its scope has recently been extended to other flaviviruses such as dengue, yellow fever, West Nile and Zika viruses, pestiviruses, pegiviruses and related viruses. Their incorporation into the meeting programme reflects the huge scientific, public health and vaccine development effort in the wider virus family, and the valuable context and knowledge this brings to the HCV field – and conversely, the extraordinary virological and therapeutic progress on HCV that may cross-fertilise flavivirus research.

This event will bring together leading experts, researchers, and healthcare professionals from around the world to discuss the latest advancements and research in the field of hepatitis C virus, flaviviruses, pestiviruses and related viruses. The program will deliver internationally renowned keynotes and plenary speakers, oral presentations selected from abstracts, rapid fire talks, and poster sessions.

Keynote Speaker

Dan Barouch, Harvard University

Dr. Dan Barouch received his Ph.D. in immunology from Oxford University and his M.D. from Harvard Medical School. He is currently the William Bosworth Castle Professor of Medicine and Professor of Immunology at Harvard Medical School, Director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, a member of the Ragon Institute of MGH, MIT, and Harvard, and part of the Bill & Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery.

His laboratory focuses on studying the immunology and pathogenesis of viral infections and developing novel vaccine and treatment strategies. His group has led the development of vaccine candidates for multiple pathogens of global significance, including HIV, Zika virus, tuberculosis, and most recently SARS-CoV-2. His recent work contributed to the development of the Johnson & Johnson COVID-19 vaccine, which is now being rolled out throughout the world. He was elected to the National Academy of Medicine in 2020.

Plenary Speakers